6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Universe Pharmaceuticals INC
Filed: September 28, 2022
Period of Report: September 28, 2022
Accession Number: 0001213900-22-059567

View Document ↗ View on SEC.gov ↗